G. Ronco

L. Bonello, F. Merletti, A. Gillio-Tos, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Cervical cancer screening programmes and policies in 18 European countries

F. Bray, E. Weiderpass, M. Hakama, 2004, British Journal of Cancer.

Description of the national situation of cervical cancer screening in the member states of the European Union.

G. Ronco, A. Anttila, 2009, European journal of cancer.

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

S. Franceschi, N. Muñoz, S. Gallus, 2005, The Lancet.

Inequalities in cervical cancer screening utilisation and results: A comparison between Italian natives and immigrants from disadvantaged countries.

G. Ronco, N. Segnan, L. Giordano, 2017, Health policy.

Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirusesting

S. Ciatto, C. Maddau, G. Ronco, 2000, British Journal of Cancer.

EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease

Y. Qiao, L. Bruni, A. Giuliano, 2012, International journal of cancer.

Occult HCV Infection: An Unexpected Finding in a Population Unselected for Hepatic Disease

P. Vineis, D. Palli, V. Krogh, 2009, PloS one.

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.

J. Cuzick, M. Zorzi, A. Del Mistro, 2010, The Lancet. Oncology.

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

N. Segnan, G. Ronco, N. Segnan, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Accuracy of the umbilical arteries Doppler flow velocity waveforms in detecting adverse perinatal outcomes in a high‐risk population

G. Ronco, N. Segnan, G. Pilu, 1996, Acta obstetricia et gynecologica Scandinavica.

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial

J. Cuzick, M. Zorzi, D. Minucci, 2007, BMJ : British Medical Journal.

Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: description of the diverse and most represented species

Paolo Vineis, Francesca Cordero, Giuseppe Matullo, 2017, Oncotarget.

Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.

A. Del Mistro, S. Girlando, A. Gillio-Tos, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

J. Cuzick, M. Zorzi, A. Del Mistro, 2008, Journal of the National Cancer Institute.

MicroRNAs as markers of progression in cervical cancer: a systematic review

A. Naccarati, A. Francavilla, C. Di Gaetano, 2018, BMC Cancer.

Recurrent squamous cell carcinoma of the vulva

G. Ronco, B. Ghiringhello, M. Preti, 2000, Cancer.

Recurrent Squamous Cell Carcinoma of the Vulva Clinicopathologic Determinants Identifying Low Risk Patients

G. Ronco, B. Ghiringhello, M. Preti, 2022 .

GP5+/6+ SYBR Green methodology for simultaneous screening and quantification of human papillomavirus.

F. Merletti, A. Gillio-Tos, L. De Marco, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Impacts of human papillomavirus vaccination for different populations: A modeling study

S. Franceschi, G. Ronco, F. Lazzarato, 2018, International journal of cancer.

New paradigms in cervical cancer prevention: opportunities and risks

Guglielmo Ronco, Paolo Giorgi Rossi, G. Ronco, 2008, BMC women's health.

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial

S. Franceschi, M. Zorzi, A. Del Mistro, 2013, BMC Infectious Diseases.

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

Joakim Dillner, Jack Cuzick, Marc Arbyn, 2008, Vaccine.

Role of HPV DNA testing in modern gynaecological practice.

G. Ronco, P. Giorgi Rossi, 2017, Best practice & research. Clinical obstetrics & gynaecology.

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.

J. Cuzick, M. Zorzi, A. Del Mistro, 2006, The Lancet. Oncology.

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting.

A. Tos, A. Del Mistro, S. Girlando, 2005, American journal of clinical pathology.

How to evaluate emerging technologies in cervical cancer screening?

Jack Cuzick, Marc Arbyn, Guglielmo Ronco, 2009, International journal of cancer.

Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide

S. Franceschi, F. X. Bosch, N. Muñoz, 2006, International journal of cancer.

The prevention of cervical cancer in HIV-infected women.

S. Franceschi, G. Ronco, 2010, AIDS.

The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs

G. Ronco, P. Giorgi Rossi, F. Baldacchini, 2014, Front. Oncol..

Occupation and lung cancer in two industrialized areas of northern Italy

P. Vineis, G. Ciccone, G. Ronco, 1988, International journal of cancer.

The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developments

M. Stoler, G. Ronco, C. Bergeron, 2015, International journal of cancer.

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

S. Rosso, J. Cuzick, M. Zorzi, 2008, The Lancet. Oncology.

Effect of circulation and discussion of cervical smears on agreement between laboratories

G. Ronco, G. Montanari, F. Parisio, 2003, Cytopathology : official journal of the British Society for Clinical Cytology.

Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more

J. Cuzick, A. Del Mistro, S. Girlando, 2018, International journal of cancer.

HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.

J. Cuzick, M. Zorzi, A. Del Mistro, 2007, European journal of cancer.

Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys

S. Franceschi, N. Muñoz, Y. Qiao, 2006, Cancer Epidemiology Biomarkers & Prevention.

Five‐year risk of CIN3 after short‐term HPV‐DNA negativity in cytology‐negative women: a population‐based cohort study

M. Zorzi, A. Del Mistro, G. Ronco, 2019, BJOG : an international journal of obstetrics and gynaecology.

Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.

G. Ronco, P. Giubilato, Renza Volante, 2007, Epidemiologia e prevenzione.

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination

S. Franceschi, J. Dillner, G. Ronco, 2015, Papillomavirus Research.

Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.

S. Franceschi, M. Zappa, G. Ronco, 2017, Preventive medicine.

Effi cacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia : a randomised controlled trial

J. Cuzick, M. Zorzi, S. Girlando, 2010 .

The differential diagnosis of primary lung cancer: inter-observer agreement and contribution of specific diagnostic procedures.

U. Pastorino, M. Bugiani, G. Ronco, 1992, Journal of clinical epidemiology.

HPV prevalence and accuracy of HPV testing to detect high‐grade cervical intraepithelial neoplasia

S. Franceschi, G. Ronco, P. Giorgi-Rossi, 2012, International journal of cancer.

The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study.

G. Collina, P. Dalla Palma, A. Buccoliero, 2009, American journal of clinical pathology.

Prevalence of human papillomavirus infection in women in Turin, Italy.

S. Franceschi, C. Meijer, P. Snijders, 2005, European journal of cancer.

Modelling patterns of clearance of HPV-16 infection and vaccination efficacy.

P. Vineis, G. Garnett, G. Ronco, 2011, Vaccine.

Quality of colposcopy and treatment--data from the national survey of Italian organised cervical screening programmes: 2006 activity.

G. Ronco, P. Giubilato, Renza Volante, 2009, Epidemiologia e prevenzione.

p16/ki67 and E6/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women.

A. Del Mistro, A. Gillio-Tos, G. Ronco, 2020, Journal of the National Cancer Institute.

Interobserver reproducibility of cytologic p16INK4a/Ki‐67 dual immunostaining in human papillomavirus‐positive women

M. Giovagnoli, G. Ronco, P. Giorgi Rossi, 2017, Cancer cytopathology.

Methods for screening and diagnosis

P. Sparén, E. Weiderpass, J. Dillner, 2007 .

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

H. Kitchener, J. Dillner, M. Hakama, 2006, International journal of cancer.

Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study.

M. Plummer, S. Franceschi, A. Del Mistro, 2012, European journal of cancer.

Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates

S. Franceschi, J. Dillner, A. Del Mistro, 2013, PloS one.

Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.

M. Federico, S. Baracco, D. Serraino, 2013, Preventive medicine.

Cervical Cancer Screening: The Transformational Role of Routine Human Papillomavirus Testing

S. Franceschi, G. Ronco, 2018, Annals of Internal Medicine.

Eurogin 2010 roadmap on cervical cancer prevention

S. Franceschi, C. Wheeler, J. Peto, 2011, International journal of cancer.

HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions.

P. Vineis, G. Garnett, G. Ronco, 2010, Epidemics.

The impact of new technologies in cervical cancer screening: Results of the recruitment phase of a large randomised controlled trial from a public health perspective

J. Cuzick, M. Zorzi, M. Merito, 2007, International journal of cancer.

The present and future of cervical cancer screening programmes in Europe.

G. Ronco, P. Giorgi Rossi, 2013, Current pharmaceutical design.

[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].

M. Zorzi, M. Zappa, G. Ronco, 2012, Epidemiologia & Prevenzione.

[Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity].

M. Zorzi, P. Dalla Palma, M. Zappa, 2012, Epidemiologia & Prevenzione.

[Indicators and standards for evaluating the program process for cervical cancer screening. Operation manual. Italian Group for Cervical Carcinoma Screening].

F. Berrino, T. Maggino, P. Dalla Palma, 1999, Epidemiologia & Prevenzione.

A Fall-off in Cervical Screening Coverage of Younger Women in Developed Countries

G. Ronco, E. Lynge, J. Patnick, 2010, Journal of medical screening.

Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms.

S. Franceschi, M. Zorzi, A. Del Mistro, 2016, European journal of cancer.

Age‐specific patterns of unsatisfactory results for conventional Pap smears and liquid‐based cytology: data from two randomised clinical trials

G. Ronco, P. Klinkhamer, J. Bulten, 2010, BJOG : an international journal of obstetrics and gynaecology.

The length of pregnancy: An echographic reappraisal

G. Ronco, T. Todros, L. Gagliardi, 1991, Journal of Clinical Ultrasound.

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer

J. Berkhof, C. Meijer, B. Lissenberg-Witte, 2020, International journal of cancer.

Interpretation of p16INK4a/Ki‐67 dual immunostaining for the triage of human papillomavirus‐positive women by experts and nonexperts in cervical cytology

A. Sapino, A. Gillio-Tos, L. De Marco, 2015, Cancer cytopathology.

Comparison of methods for assessing the probability of exposure in metal plating, shoe and leather goods manufacture and vine growing.

Dick Heederik, Lucia Miligi, Hans Kromhout, 1996 .

Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.

P. Snijders, F. Merletti, A. Gillio-Tos, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Re: lead time and down-staging in the survival of cervical cancer cases detected by screening.

D. Serraino, M. Zappa, G. Ronco, 2013, Preventive medicine.

[Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)].

C. Magnani, L. De Marco, G. Ronco, 2012, Epidemiologia & Prevenzione.

hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).

A. Del Mistro, M. Zappa, G. Ronco, 2015, Epidemiologia e prevenzione.

Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness.

M Arbyn, E Lynge, G Ronco, 2000, European journal of cancer.

Primary Screening by Human Papillomavirus Testing: Development, Implementation, and Perspectives

J. Cuzick, C. Meijer, G. Ronco, 2020 .

Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial

A. Del Mistro, A. Gillio-Tos, L. De Marco, 2022, International journal of cancer.